CD4 and neoplasm: More recently, the role of tumor-infiltrating CD4+ T cells in the anti-tumor immune response, particularly in the context of immunotherapies such as immune checkpoint blockade (ICB) and adoptive cell transfer (ACT), has garnered increased interest [4, 5].